{"denoms":[{"counts":[{"groupId":"BG000","value":"18"},{"groupId":"BG001","value":"63"},{"groupId":"BG002","value":"112"},{"groupId":"BG003","value":"193"}],"units":"Participants"}],"groups":[{"description":"Participants received CZP sc as a fixed dose based on their body weight Q2W or Q4W throughout the study. Participants started with 3 loading doses of CZP at Weeks 0, 2, and 4 followed by a maintenance dose for the duration of the study.","id":"BG000","title":"Any CZP Dose - Weight Group: 10 - <20 kg"},{"description":"Participants received CZP sc as a fixed dose based on their body weight Q2W throughout the study. Participants started with 3 loading doses of CZP at Weeks 0, 2, and 4 followed by a maintenance dose for the duration of the study.","id":"BG001","title":"Any CZP Dose - Weight Group: 20 - <40 kg"},{"description":"Participants received CZP sc as a fixed dose based on their body weight Q2W throughout the study. Participants started with 3 loading doses of CZP at Weeks 0, 2, and 4 followed by a maintenance dose for the duration of the study.","id":"BG002","title":"Any CZP Dose - Weight Group: >=40 kg"},{"description":"Total of all reporting groups","id":"BG003","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"1.3","value":"5.4"},{"groupId":"BG001","spread":"2.0","value":"9.1"},{"groupId":"BG002","spread":"2.2","value":"14.5"},{"groupId":"BG003","spread":"3.8","value":"11.9"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"18"},{"groupId":"BG001","value":"55"},{"groupId":"BG002","value":"13"},{"groupId":"BG003","value":"86"}],"title":"24 months - <12 years"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"8"},{"groupId":"BG002","value":"99"},{"groupId":"BG003","value":"107"}],"title":"12 - <18 years"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Age, Customized","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"11"},{"groupId":"BG001","value":"43"},{"groupId":"BG002","value":"76"},{"groupId":"BG003","value":"130"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"7"},{"groupId":"BG001","value":"20"},{"groupId":"BG002","value":"36"},{"groupId":"BG003","value":"63"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"4"},{"groupId":"BG003","value":"5"}],"title":"American Indian/ Alaska Native"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"3"},{"groupId":"BG003","value":"5"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"6"},{"groupId":"BG003","value":"6"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"}],"title":"Native Hawaiian or Other Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"17"},{"groupId":"BG001","value":"53"},{"groupId":"BG002","value":"85"},{"groupId":"BG003","value":"155"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"14"},{"groupId":"BG003","value":"22"}],"title":"Other/Mixed"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race/Ethnicity, Customized","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"10"},{"groupId":"BG001","value":"18"},{"groupId":"BG002","value":"27"},{"groupId":"BG003","value":"55"}],"title":"Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"8"},{"groupId":"BG001","value":"45"},{"groupId":"BG002","value":"85"},{"groupId":"BG003","value":"138"}],"title":"Not Hispanic or Latino"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race/Ethnicity, Customized","unitOfMeasure":"Participants"}],"populationDescription":"Baseline Characteristics refers to the Safety Set (SS) which consisted of all study participants in the Enrolled Set (ES) who have received at least 1 dose of study medication."}